Traditionalȱ medicineȱ (TM)ȱ hasȱ alwaysȱ maintainedȱ itsȱ popularic
The third National Pharmaceutical Sector Strategic Plan 2015/16-2019/20 (NPSSP III) has been developed to support the implementation of the National Medicines Policy (NMP) 2015. The NPSSP III was developed through wide consultations with diverse stakeholders including representatives from the private sector, academia, development partners, civil society and all relevant government institutions. The development process was led by a task team set up by the Pharmacy Division of Ministry of Health (MoH) supported by a team of consultants.
This report was made with Technical Assistance from the USAID/SURE Program
Agriculture is and will, in the medium term, remain central to Uganda’s economic growth and poverty reduction. It employs nearly 80% of the population1, contributes approximately 25% to the Gross Domestic Product (GDP) and generates 40% of the country’s exports.
The manual includes data sheets in the Annex. It deals with wastes that are created in the course of surgical, medical, laboratory and radiological activities with the exception of specialties such as oncology, nuclear medicine or prosthetic/ orthotic workshops. It deals mainly with so-called hazardous or special medical waste except for genotoxic waste such as cytotoxic substances or radioactive material, which are wastes that ICRC health care activities generally do not produce.
The overall purpose of the review was to estimate the extent to which the Member State mechanism had progressed in achieving its objectives in the period 2012–2016; to identify gaps and remaining challenges; and to make recommendations on the way forward.
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, Anti-TB medicines, Reproductive Health items, selected Laboratory commodities, Vaccines and selected medicines for treatment of Opportunistic Infections In the Republic of UgandaThis report serves to: - Act as an early warning indicator for potential stock outs and possible expiries of EMHS- Identify challenges and recommendations to avert supply interruptions- Encourage preparation and sharing of joint supply plans with stakeholders- Identify strategies for regularly reviewing supply plans for all the commodities
This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate stock outs and expiries of ARVs & HIV test kits, ACTs, Anti-TB medicines, Reproductive Health items, selected Laboratory commodities,Vaccines and selected medicines for treatment of Opportunistic Infections In the Repubic of Uganda.
This manual is intended to provide process evaluation technical assistance to OSH staff, grantees and partners. It defines process evaluation and describes the rationale, benefits, key data collection components, and program evaluation management procedures. It also discusses how process evaluation links with outcome evaluation and fits within an overall approach to evaluating comprehensive tobacco control programs.
This guide presents communication guidance for countries introducing human papillomavirus (HPV) vaccine at the national or sub-national levels. HPV vaccination is a key strategy for comprehensive cervical cancer control and prevention. By the end of 2015, more than 65 countries introduced HPV vaccine into their national immunization programmes, with more than 30 of them were approved for Gavi-supported introductions
In 1985 WHO convened a conference in Nairobi on the rational use of drugs, since that time efforts have been increased to improve drug uses practices.An essential tool for such work is an objective measure of drug use in health facilities.
Welcome to the first issue of The Lab Digest, a quarterly newsletter that brings you updates and insights from the world of laboratory and diagnostics, a brainchild of the department of National Health Laboratory and Diagnostic Services of the Ministry of Health.
We are deeply delighted to have made it this far, and we can only pledge better in our subsequent issues. Special appreciation to the editorial team and the National Health Laboratory and Diagnostic Services Management.
